This inventor holds 1 USPTO granted patent. Top assignee: Icn Pharmaceuticals, Inc.. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Vjera Pejanovic: Innovator in Ribo-C-Nucleosides
Introduction
Vjera Pejanovic is a notable inventor based in Belgrade, RS. She has made significant contributions to the field of biochemistry, particularly in the development of novel procedures for obtaining ribo-C-nucleosides. Her work has implications for various applications in pharmaceuticals and biotechnology.
Latest Patents
Vjera Pejanovic holds a patent for "Procedures for obtaining ribo-C-nucleosides." This patent includes innovative methods for synthesizing compounds such as 2-.beta.-D-ribofuranosylthiazole-4-carboxylamide (tiazofirin) and 2-.beta.-D-ribofuranosylselenazole-4-carboxylamide (sylenazofurin). The procedures involve introducing a cyano group at the 1' position of a ribose and converting it into various functional groups, ultimately leading to the formation of heterocyclic rings.
Career Highlights
Vjera Pejanovic is currently associated with Icn Pharmaceuticals, Inc., where she continues her research and development efforts. Her expertise in nucleoside chemistry has positioned her as a valuable asset in the pharmaceutical industry.
Collaborations
Throughout her career, Vjera has collaborated with esteemed colleagues such as Kandasamy Ramasamy and Arthur F Lewis. These collaborations have further enhanced her research and contributed to the advancement of her projects.
Conclusion
Vjera Pejanovic is a pioneering inventor whose work in ribo-C-nucleosides showcases her innovative spirit and dedication to advancing biochemistry. Her contributions are expected to have a lasting impact on the pharmaceutical field.